ArticleAmerican journal of reproductive immunology (New York, N.Y. : 1989)2026
SARS-CoV-2 Chronic Intervillositis: Variations of Maternal Antiviral Response.
Article in American journal of reproductive immunology (New York, N.Y. : 1989), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- SARS-CoV-2 Chronic Intervillositis: Variations of Maternal Antiviral Response.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
problemPlacental compromise is a determining factor in the outcome of pregnancies complicated by maternal SARS-CoV-2 infection. Chronic histiocytic intervillositis (CHI) is the initial response to SARS-CoV-2 infection, but the underlying mechanisms are poorly understood. The aim of this study was to assess the extent and composition of the placental inflammatory response and to explore the relationship between the severity of inflammation and viral levels in the placenta. METHODS OF STUDY: Placentas from 43 women who tested positive for SARS-CoV-2 infection at the time of delivery at a single tertiary medical center (8/2020 to 10/2022) were evaluated using quantitative reverse transcription polymerase chain reaction (qRT-PCR), histopathological, ultrastructural, and in situ hybridization studies.
resultsThere was a significant association between viral load and severity of CHI with notable involvement of CD20-positive B lymphocytes (100% in patients with diffuse CHI vs 0% in the patients with no inflammation). Both PCR-positive and PCR-negative placentas exhibited varying degrees of inflammation. Electron microscopy confirmed viral particles in PCR- and CHI-negative samples, Additionally, mean gestational age at delivery was significantly lower in the PCR-positive patients.
conclusionThese findings highlight the complex interplay between maternal SARS-CoV-2 infection and placental inflammation. The inflammatory response may extend beyond the presence of the virus per se, and viral load differences linked to individual immune response variability may influence the development of inflammation. Further research is needed to elucidate the mechanisms by which SARS-CoV-2 impacts maternal and neonatal health outcomes and provide insight into the implications of viral infections during pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.